Targeting Adhesion in Fungal Pathogen Candida Albicans

H Martin, K Kavanagh… - Future Medicinal …, 2021 - Taylor & Francis
Fungal infections with increasing resistance to conventional therapies are a growing
concern. Candida albicans is a major opportunistic yeast responsible for mucosal and …

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review

M Faiyazuddin, A Sophia, S Ashique… - Frontiers in …, 2023 - frontiersin.org
The outbreak of a fatal black fungus infection after the resurgence of the cadaverous COVID-
19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new …

The lipopeptides fengycin and iturin are involved in the anticandidal activity of endophytic Bacillus sp. as determined by experimental and in silico analysis

S Banerjee, S Sen, A Bhakat… - Letters in applied …, 2022 - academic.oup.com
In this study, an endophytic Bacillus sp. strain (K7) was isolated from the medicinally
important ornamental plant, Jasminum officinale. Biochemical analyses were conducted to …

[HTML][HTML] Anti-Candida activity of essential oils from Lamiaceae plants from the Mediterranean area and the Middle East

G Potente, F Bonvicini, GA Gentilomi, F Antognoni - Antibiotics, 2020 - mdpi.com
Extensive documentation is available on plant essential oils as a potential source of
antimicrobials, including natural drugs against Candida spp. Yeasts of the genus Candida …

LC-MS/MS profiling and analysis of Bacillus licheniformis extracellular proteins for antifungal potential against Candida albicans

JS Prusty, A Kumar - Journal of Proteomics, 2024 - Elsevier
Candida albicans, a significant human pathogenic fungus, employs hydrolytic proteases for
host invasion. Conventional antifungal agents are reported with resistance issues from …

In silico-driven identification and experimental confirmation of antifungal proteins (AFPs) against Candida albicans

JS Prusty, A Kumar - Biochimie, 2025 - Elsevier
Mycoses infect millions of people annually across the world. The most common mycosis
agent, Candida albicans is responsible for a great deal of illness and death. C. albicans …

A plant mannose‐binding lectin and fluconazole: Key targets combination against Candida albicans

M Del Rio, MB Radicioni, ÉO Mello… - Journal of Applied …, 2022 - academic.oup.com
Aims This study aimed to evaluate the combined effect of a mannose‐binding lectin Helja
with fluconazole (FLC) on Candida albicans and to get insights about the joint action …

Target shortage and less explored multiple targeting: hurdles in the development of novel antifungals but overcome/addressed effectively through structural …

A Jha, A Vimal, A Kumar - Briefings in Bioinformatics, 2021 - academic.oup.com
Billions of people are affected by fungal infection worldwide, which is a major cause of
morbidity and mortality in humans. Regardless of development in the field of antifungal …

Glycosylated heterocyles emulsified with antifungal fraction of Moringa oleifera for potentiation of mycolytic activity

M Bhatia, N Karnekar, O Halingale… - Natural Product …, 2024 - Taylor & Francis
To enhance the clinical effect of antifungal medications for treating deadly fungal infections
there is an increasing demand for novel treatments. Exploration of multiple-drug targeting in …

Emerging Prevalence of Fungal Infections and Challenges in Development of New Antifungals

G Gajera, N Thakkar, V Kothari - Human Fungal Diseases, 2025 - taylorfrancis.com
Though fungi are primarily saprophytes, they can pose risk of serious infections to
immunocompromised people. In recent decades, owing to an increase in the population of …